Paper41228344
High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T).
Arad A and 13 others. Cancers (Basel), 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T). Papers, record 41228344. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41228344
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39653116 | Efficacy and Safety of Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis. | J Clin Oncol | 2025 | https://conductscience.org/library/papers/39653116 | PubMed |
| 2 | 27412889 | T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma. | Blood | 2016 | https://conductscience.org/library/papers/27412889 | PubMed |
| 3 | 37176053 | Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176053 | PubMed |
| 4 | 33608658 | CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial. | Bone Marrow Transplant | 2021 | https://conductscience.org/library/papers/33608658 | PubMed |
| 5 | 30592986 | ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30592986 | PubMed |
| 6 | 38821074 | Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee. | Lancet Oncol | 2024 | https://conductscience.org/library/papers/38821074 | PubMed |
| 7 | 37471687 | Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37471687 | PubMed |
| 8 | 40216223 | Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation. | J Thromb Haemost | 2025 | https://conductscience.org/library/papers/40216223 | PubMed |
| 9 | 34595461 | The Many Faces of Cytokine Release Syndrome-Related Coagulopathy. | Clin Hematol Int | 2021 | https://conductscience.org/library/papers/34595461 | PubMed |
| 10 | 36906275 | Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome. | Transplant Cell Ther | 2023 | https://conductscience.org/library/papers/36906275 | PubMed |
| 11 | 28928126 | Chimeric antigen receptor T-cell therapies for multiple myeloma. | Blood | 2017 | https://conductscience.org/library/papers/28928126 | PubMed |
| 12 | 32683907 | Fibrinogen Diagnostics in Major Hemorrhage. | Crit Rev Anal Chem | 2022 | https://conductscience.org/library/papers/32683907 | PubMed |
| 13 | 31786240 | Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies. | Biol Blood Marrow Transplant | 2020 | https://conductscience.org/library/papers/31786240 | PubMed |
| 14 | 34521106 | Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy. | Blood Adv | 2021 | https://conductscience.org/library/papers/34521106 | PubMed |
| 15 | 28924019 | Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. | Blood | 2017 | https://conductscience.org/library/papers/28924019 | PubMed |
| 16 | 39521987 | New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies. | Exp Hematol Oncol | 2024 | https://conductscience.org/library/papers/39521987 | PubMed |
| 17 | 32877523 | Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma. | Blood Adv | 2020 | https://conductscience.org/library/papers/32877523 | PubMed |
| 18 | 31378662 | A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial. | Lancet Haematol | 2019 | https://conductscience.org/library/papers/31378662 | PubMed |
| 19 | 29812997 | T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29812997 | PubMed |
| 20 | 22160384 | B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. | Blood | 2012 | https://conductscience.org/library/papers/22160384 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41228344
GET https://conductscience.org/api/papers/v1/41228344/references?page=2